Discover
MAZE
Maze Therapeutics, Inc.
27.11
2 x 19.91
2 x 35.55
bid
ask
+
1.23
4.75%
2 @ 04:01 PM
27.11 +0.00 (0.00%)
| Ytd | -34.56% | |
| 1y | -5.74% |
25.88
day range
27.19
22.39
52 week range
51.83
| Open | 25.88 | Prev Close | 25.88 | Low | 25.88 | High | 27.19 | Mkt Cap | 1.51B |
| Vol | 670.93K | Avg Vol | 565.24K | EPS | -2.48 | P/E | N/A | Forward P/E | -8.41 |
| Beta | 2.16 | Short Ratio | 12.34 | Inst. Own | 106.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 26.87 | 200-d Avg | 32.71 | 1yr Est | 61.50 |
| Income Statement | |||
| Operating Expenses | 48.04M | ||
| Research and Development Expense | 34.94M | ||
| Selling, General and Administrative Expense | 13.10M | ||
| Operating Income | -48.03M | ||
| Interest Expense | 931.00K | ||
| Net Income | -44.73M | ||
| Net Income Common Stock | -44.73M | ||
| Net Income Common Stock (USD) | -44.73M | ||
| Consolidated Income | -44.73M | ||
| Earnings per Basic Share | -0.76 | ||
| Earnings per Basic Share (USD) | -0.76 | ||
| Earnings per Diluted Share | -0.76 | ||
| Earning Before Interest & Taxes (EBIT) | -43.80M | ||
| Earning Before Interest & Taxes (USD) | -43.80M | ||
| Weighted Average Shares | 59.00M | ||
| Weighted Average Shares Diluted | 59.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 203.73M | ||
| Cash and Equivalents (USD) | 203.73M | ||
| Investments | 292.27M | ||
| Investments Current | 208.44M | ||
| Investments Non-Current | 83.82M | ||
| Current Assets | 420.42M | ||
| Property, Plant & Equipment Net | 22.83M | ||
| Total Assets | 531.63M | ||
| Debt Current | 4.88M | ||
| Total Debt | 60.42M | ||
| Current Liabilities | 22.96M | ||
| Debt Non-Current | 55.54M | ||
| Total Liabilities | 78.50M | ||
| Accumulated Retained Earnings (Deficit) | -558.48M | ||
| Accumulated Other Comprehensive Income | -435.00K | ||
| Shareholders Equity | 453.12M | ||
| Shareholders Equity (USD) | 453.12M | ||
| Assets Non-Current | 111.20M | ||
| Total Debt (USD) | 60.42M | ||
| Liabilities Non-Current | 55.54M | ||
| Trade and Non-Trade Payables | 2.21M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.23M | ||
| Net Cash Flow from Financing | 147.44M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.88M | ||
| Capital Expenditure | -107.00K | ||
| Issuance (Purchase) of Equity Shares | 147.26M | ||
| Issuance (Repayment) of Debt Securities | -53.00K | ||
| Net Cash Flow from Investing | -128.51M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -128.40M | ||
| Net Cash Flow from Operations | -15.05M | ||
| Share Based Compensation | 9.19M | ||